Cargando…

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol

BACKGROUND: Treatment of schizophrenia frequently includes prolonged benzodiazepine administration despite a lack of evidence of its use. It is often difficult to discontinue benzodiazepines because of the development of dependence. We aim to assess if melatonin can facilitate the withdrawal of prol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baandrup, Lone, Fagerlund, Birgitte, Jennum, Poul, Lublin, Henrik, Hansen, Jane L, Winkel, Per, Gluud, Christian, Oranje, Bob, Glenthoj, Birte Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3213077/ https://www.ncbi.nlm.nih.gov/pubmed/21975110 http://dx.doi.org/10.1186/1471-244X-11-160

Ejemplares similares

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial
por: Baandrup, Lone, et al.
Publicado: (2016)

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
por: Rasmussen, Jesper Østrup, et al.
Publicado: (2021)

A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
por: Baandrup, Lone, et al.
Publicado: (2015)

Effect of a dynamic lighting intervention on circadian rest-activity disturbances in cognitively impaired, older adults living in a nursing home: A proof-of-concept study
por: Baandrup, Lone, et al.
Publicado: (2021)

Treatment of sleep disturbances in trauma-affected refugees: Study protocol for a randomised controlled trial
por: Sandahl, Hinuga, et al.
Publicado: (2017)

F21. ELECTROPHYSIOLOGICAL PARAMETERS OF SELECTIVE ATTENTION IN ADOLESCENTS WITH A FIRST EPISODE OF PSYCHOSIS: A COMPARISON WITH ADHD
por: Selten, Iris, et al.
Publicado: (2018)

F34. AUDITORY SENSORY GATING IN YOUNG ADOLESCENTS WITH EARLY-ONSET PSYCHOSIS: A COMPARISON WITH ADHD
por: Lemvigh, Cecilie, et al.
Publicado: (2018)

Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial
por: Sandahl, Hinuga, et al.
Publicado: (2021)

Melatonin and cortisol profiles in late midlife and their association with age-related changes in cognition
por: Waller, Katja Linda, et al.
Publicado: (2016)

F236. CLONIDINE NORMALIZES MMN IN SCHIZOPHRENIA PATIENTS ON STABLE MEDICATION
por: Kruiper, Caitlyn, et al.
Publicado: (2018)

Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
por: Ebdrup, Bjørn H, et al.
Publicado: (2012)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Effects of Blocking D2/D3 Receptors on Mismatch Negativity and P3a Amplitude of Initially Antipsychotic Naïve, First Episode Schizophrenia Patients
por: Düring, Signe, et al.
Publicado: (2015)

Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study
por: Jennum, Poul, et al.
Publicado: (2016)

Sleep impairments in refugees diagnosed with post-traumatic stress disorder: a polysomnographic and self-report study
por: Ansbjerg, Mia Beicher, et al.
Publicado: (2023)

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis
por: Rasmussen, Jesper Ø., et al.
Publicado: (2022)

A nation-wide twin study of social cognition in schizophrenia spectrum disorders
por: Lemvigh, Cecilie K., et al.
Publicado: (2022)

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
por: Ishøy, Pelle L, et al.
Publicado: (2014)

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients
por: Ebdrup, Bjørn H., et al.
Publicado: (2019)

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and z-drugs consumption in nine European countries
por: Clay, Emilie, et al.
Publicado: (2012)

Attitudes and Difficulties Associated with Benzodiazepine Discontinuation
por: Takeshima, Masahiro, et al.
Publicado: (2022)

The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trial
por: Glenthøj, Louise B, et al.
Publicado: (2015)

Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial
por: Coteur, Kristien, et al.
Publicado: (2023)

Concurrent functional magnetic resonance imaging and electroencephalography assessment of sensory gating in schizophrenia
por: Bak, Nikolaj, et al.
Publicado: (2013)

Use of melatonin in children and adolescents with idiopathic chronic insomnia: a systematic review, meta-analysis, and clinical recommendation
por: Edemann-Callesen, Henriette, et al.
Publicado: (2023)

The association between benzodiazepine and non-benzodiazepine and suicide: a nationwide cohort study
por: Høier, N., et al.
Publicado: (2022)

Use of melatonin for children and adolescents with chronic insomnia attributable to disorders beyond indication: a systematic review, meta-analysis and clinical recommendation
por: Edemann-Callesen, Henriette, et al.
Publicado: (2023)

The short-term and long-term adverse effects of melatonin treatment in children and adolescents: a systematic review and GRADE assessment
por: Händel, Mina Nicole, et al.
Publicado: (2023)

Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuation
por: Fluyau, Dimy, et al.
Publicado: (2018)

Experiences with benzodiazepine use, tapering, and discontinuation: an Internet survey
por: Reid Finlayson, Alistair J., et al.
Publicado: (2022)

T60. GENETIC INFLUENCES ON MEMORY FUNCTIONS AND RELATED BRAIN STRUCTURES AND ASSOCIATIONS WITH SCHIZOPHRENIA SPECTRUM DISORDERS: A NATION-WIDE TWIN STUDY
por: Lemvigh, Cecilie, et al.
Publicado: (2020)

Attenuated mismatch negativity in patients with first-episode antipsychotic-naive schizophrenia using a source-resolved method
por: Randau, M., et al.
Publicado: (2019)

Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary care
por: Coteur, Kristien, et al.
Publicado: (2022)

Is melatonin helpful in stopping the long-term use of hypnotics? A discontinuation trial
por: Vissers, Frans H. J. A., et al.
Publicado: (2007)

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL
por: Kristensen, Tina, et al.
Publicado: (2020)

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
por: Kristensen, Tina D., et al.
Publicado: (2020)

Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference?
por: Kollen, Boudewijn J, et al.
Publicado: (2012)

Melatonin Secretion Pattern in Critically Ill Patients: A Pilot Descriptive Study
por: Boyko, Yuliya, et al.
Publicado: (2017)

Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register
por: Hilker, Rikke, et al.
Publicado: (2017)

Serum melatonin concentration in critically ill patients randomized to sedation or non-sedation
por: Oxlund, Jakob, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_d7kth0ggt2dqh6nlecs2u4l5e6